Human Anti-LILRA4 scFv-Fc Chimera (VS-0325-FY103) (CAT#: VS-0325-FY103)

The anti-LILRA4 scFv-Fc antibody is designed to specifically target LILRA4, a receptor involved in immune regulation. It is engineered with a scFv-Fc format to enhance stability and prolong half-life in vivo. This antibody can be used in both in vitro and in vivo studies to explore the role of LILRA4 in diseases like cancer and autoimmune disorders.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location and Protein Expression
Normal Tissue

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Specificity
  • Human LILRA4
  • Species Reactivity
  • Human
  • Applications
  • Flow Cytometry
  • Related Disease
  • Cancer, autoimmune disease

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Target

  • Alternative Names
  • ILT7; CD85g
  • Long Name
  • leukocyte immunoglobulin like receptor A4
  • Cellular Localization
  • Cell membrane
  • Post Translation Modifications
  • Glycosylation at Asn138, Asn239, Asn279, and Asn300
    Modification sites at PhosphoSitePlus
    Glycosylation from GlyGen 4 sites
  • Function
  • Functions coreceptor to limit the innate immune responses to viral infections; signaling occurs via FCER1G (PubMed:16735691, 19564354).
    Down-regulates the production of IFNA1, IFNA2, IFNA4, IFNB1 and TNF by plasmacytoid dendritic cells that have been exposed to influenza virus or cytidine-phosphate-guanosine (CpG) dinucleotides, indicating it functions as a negative regulator of TLR7 and TLR9 signaling cascades.

Recommended Products

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "LILRA4"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products ScFv Antibody Products Fab Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-0325-FY103. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare